|
Originally published In Press as doi:10.1074/jbc.M004497200 on July 25, 2000
J. Biol. Chem., Vol. 275, Issue 41, 32277-32280, October 13, 2000
MioC Is an FMN-binding Protein That Is Essential for
Escherichia coli Biotin Synthase Activity in
Vitro*
Olwen M.
Birch ,
Kirsty S.
Hewitson§¶,
Martin
Fuhrmann ,
Knut
Burgdorf ,
Jack E.
Baldwin§,
Peter L.
Roach **, and
Nicholas M.
Shaw 
From the Biotechnology Research, Lonza A.G., CH-3930
Visp, Switzerland, § Dyson Perrins Laboratory, University of
Oxford, South Parks Road, Oxford OX1 3QY, United Kingdom, and the
Department of Chemistry, University of Southampton, Highfield,
Southampton SO17 1BJ, United Kingdom
Received for publication, May 24, 2000, and in revised form, July 10, 2000
 |
ABSTRACT |
Biotin synthase is required for the conversion of
dethiobiotin to biotin and requires a number of accessory proteins and
small molecule cofactors for activity in vitro. We have
previously identified two of these proteins as flavodoxin and
ferredoxin (flavodoxin) NADP+ reductase. We now report the
identification of MioC as a third essential protein, together with its
cloning, purification, and characterization. Purified MioC has a
UV-visible spectrum characteristic of a flavoprotein and contains
flavin mononucleotide. The presence of flavin mononucleotide and the
primary sequence similarity to flavodoxin suggest that MioC may
function as an electron transport protein. The role of MioC in the
biotin synthase reaction is discussed, and the structure and function
of MioC is compared with that of flavodoxin.
 |
INTRODUCTION |
Biotin synthase (BioB) catalyzes the final step of the biotin
biosynthetic pathway, where a sulfur atom is inserted between the
unactivated methyl and C-6 methylene carbon atoms of dethiobiotin (1)
(Fig. 1). Catalytic activity has not yet
been consistently observed for this reaction in vitro
(2-4). The activity measured in vitro requires a complex
mixture of small molecules and accessory proteins (3, 5-7). Cysteine
is the initial source of the sulfur atom for the reaction, and
Fe2+, dithiothreitol, NADPH,
S-adenosylmethionine, and one of the amino acids asparagine,
aspartate, glutamine, or serine are required (7). At least three other
proteins are required for biotin synthase activity. Two have been
identified as flavodoxin and ferredoxin (flavodoxin) NADP+
reductase (6, 7, 9). These proteins are thought to provide an electron
transfer pathway from NADPH to the Fe-S
cluster1 of biotin synthase.
The reduced Fe-S cluster has been proposed to reductively cleave
S-adenosylmethionine to give methionine and a
5'-deoxyadenosyl radical (7, 10). Evidence from experiments with
deuterium-labeled dethiobiotin suggests that the 5'-deoxyadenosyl radical abstracts a hydrogen atom directly from dethiobiotin (11). Two
recent reports demonstrated that the Fe-S cluster of biotin synthase
also serves as the immediate sulfur donor for the dethiobiotin to
biotin conversion (4, 12). The Fe-S cluster of biotin synthase may
therefore have a dual function, and Fe-S cluster forming proteins, such
as IscS, IscU and IscA, may thus be required for catalytic activity
(13-15). However, the mechanism of Fe-S cluster formation in
vivo remains unknown.
A third protein required for biotin synthase activity in
vitro has previously been reported (6, 7) but not identified. This
protein eluted from a Q-Sepharose column at a NaCl concentration of
~0.5 M and required TPP to stabilize its activity during
purification. We have now purified this protein, obtained a N-terminal
amino acid sequence and identified it as MioC. In this paper we also report the cloning, overexpression, and characterization of MioC.
 |
MATERIALS AND METHODS |
Chemicals--
All chemicals were of reagent grade and unless
otherwise stated were obtained from either Sigma or Fluka. Restriction
enzymes and molecular biology reagents were from Promega, and
oligonucleotides were from Genosys. [14C]Dethiobiotin
(57.2 mCi/mmol) was custom synthesized by Isotopchem (Ganagobie,
France). Recombinant flavodoxin was purified from Escherichia
coli (16).
Initial Purification and Sequencing of MioC--
MioC was first
purified from an extract of E. coli BM4062 that contained
the plasmid pBO30A-15/9 (see Ref. 7 for details of bacterial strains,
plasmids, cell growth, and preparation of extracts). The amino acid
sequence was determined with a model 477A Microsequencer (Applied
Biosystems) after cutting the protein band from a polyvinylidene
difluoride membrane (from blotting an SDS-PAGE gel) stained with
Amido Black (17).
Cloning, Overexpression, and Purification of MioC--
Standard
methods for the manipulation of DNA were used (18). MioC was initially
cloned from an E. coli Kohara gene bank. The mioC
gene was identified by hybridization against a specific oligonucleotide
formulated from the mioC DNA sequence (19) and then cloned
to form plasmid pMO4-1. The mioC gene was then amplified by
polymerase chain reaction from pMO4-1 and ligated into the pGEM-T
vector. The primers used were: forward,
5'-CCATGGCAGATATCACTCTTATCAGCGGC-3'; reverse,
5'-GGATCCTTATTTGAGTAAATTAACCCACGATCCC-3'. A 0.4-kilobase fragment encoding the mioC gene was then excised from the
pGEM-T vector with NcoI and BamHI and subcloned
into the pET 24d(+) vector (Novagen) to generate an expression vector
for MioC, pMIO.
E. coli BL21(DE3) cells were transformed with pMIO and grown
at 37 °C in 2TY medium containing 30 µg/ml kanamycin. When the attenuance at 600 nm (D600) reached 1.0, isopropyl- -D-thiogalactoside was added to a final
concentration of 0.1 mM. After 2.5 h the cells were
harvested by centrifugation at 4 °C and stored at 80 °C.
Purification of MioC was carried out at 4 °C. Frozen cells
containing pMIO (~100 g of wet weight) were thawed and resuspended in
300 ml of 50 mM Tris-HCl buffer, pH 7.5, containing 1 mM dithiothreitol. Chicken egg white lysozyme was added
(0.5 mg/ml), the mixture was stirred for 15 min, and Triton X-100 was
added to 1.0% (w/v). After a further 15 min, the cell debris was
removed by centrifugation for 30 min at 15,000 × g.
The resulting cell-free supernatant was loaded onto a 285.0 ml
Q-Sepharose HP column that had been equilibrated with 50 mM
Tris-HCl buffer, pH 7.5 (buffer A). Proteins were eluted with a linear
gradient of NaCl from 0 to 600 mM in buffer A over 10 column volumes. Fractions containing MioC were concentrated to 50 mg/ml, and 7 ml was loaded onto a 700-ml column of Superdex 75 that had
been equilibrated with buffer A. Proteins were eluted isocratically
with the same buffer. The purest MioC containing fractions (>95% as
judged by SDS-PAGE), were combined, concentrated to ~40 mg/ml, and
stored at 80 °C.
Measurement of Biotin Synthase Activity in Vitro--
To assay
biotin synthase activity in vitro and the involvement of
MioC, the incorporation of radioactive label from
[14C]dethiobiotin into biotin was measured in the
presence of biotin synthase and protein fractions. The assay was as
follows (7): enriched fractions of biotin synthase and ferredoxin
(flavodoxin) NADP+ reductase and pure flavodoxin were
incubated in a final volume of 250 µl at pH 7.5 with
Fe2+-gluconate (50 nmol), NADPH (25 nmol), thiamine
pyrophosphate (25 nmol), S-adenosylmethionine (23 nmol),
asparagine (3.75 µmol), dithiothreitol (250 nmol), Hepes buffer (25 µmol), and [14C]dethiobiotin (0.1 µCi, 1.95 nmol)
plus cysteine (83 nmol). After incubation at 37 °C for 1 h, the
reaction was stopped by the addition of 250 µl of 12.5% (w/v)
trichloroacetic acid. [14C]Dethiobiotin and
[14C]biotin were then purified before analysis by TLC or
HPLC (7).
Spectroscopic Studies--
UV-visible absorption spectra were
measured over the scan range 300-800 nm using a Shimadzu UV-1601
spectrophotometer at protein concentrations of 0.5 mg/ml in 50 mM Tris-HCl buffer, pH 7.5. Electrospray ionization mass
spectra were recorded on a Micromass BioQ II-ZS triple quadrupole mass
spectrometer. Samples (10 µl) were introduced into the electrospray
source via a loop injector as a solution with a final
protein concentration of 5 pmol/µl in water:acetonitrile (1:1 v/v)
containing 0.2% formic acid. Spectra of the MioC flavin cofactor were
recorded under negative ion conditions over the scan range 418-618 Da.
Flavin Analysis--
A Waters HPLC system fitted with an ODS
Hypersil column (250 × 4.6 mm) and a Jasco FP-920 intelligent
fluorescence detector were used for these experiments. The column was
calibrated with FMN and FAD standards (10- and 30-µl
injections of solutions with a concentration of 0.1 mg/ml). The mobile
phase was acetonitrile/water/trifluoroacetic acid (10.0% (w/v) in
water)/phosphoric acid (14:84:1.5:0.09), and the flow rate was 0.5 ml/min. The excitation wavelength for the fluorescence detector was 430 nm, and the emission wavelength was 525 nm. Purified MioC was mixed
with a solution of 5.0% (w/v) trichloroacetic acid in water, and the
precipitated protein was removed by centrifugation at room temperature.
The resulting supernatant was injected onto the column, and the results
were compared with those from the standard samples of FMN and FAD.
Molecular Mass Determination--
The apparent molecular mass of
MioC was determined using a Superdex 200 HR 10/30 column equilibrated
with 100 mM Tris-HCl, pH 7.5, and with a range of NaCl
concentrations (0.25, 1.0, and 2.0 M) at a flow rate of 0.5 ml/min. The column was calibrated with ribonuclease A (13.7 kDa),
chymotrypsinogen A (25 kDa), ovalbumin (43 kDa), and bovine serum
albumin (67 kDa) (Gel Filtration Calibration Kit; Amersham Pharmacia
Biotech). An elution volume parameter (Kav) was
calculated for each of the calibration proteins at the various salt
concentrations, and a calibration curve was constructed. By calculating
Kav for MioC and flavodoxin, the native
molecular masses of these proteins were established.
Gel Electrophoresis--
Both SDS-PAGE (15.0%) and native gel
(20.0%) electrophoresis were performed using standard techniques with
a Bio-Rad Mini Protean II kit. SDS-PAGE (10-15%) was also carried out
with the Phast System from Amersham Pharmacia Biotech.
 |
RESULTS |
Evidence That the MioC Protein Is Required for Biotin Synthase
Activity in Vitro--
We have shown previously that a number of low
molecular weight compounds plus at least flavodoxin, ferredoxin
(flavodoxin) NADP+ reductase, and a third protein are
essential for biotin synthase activity in vitro (6, 7). We
have now identified the third essential protein as MioC, which we
purified on the basis of its activity in a biotin synthase assay (7).
When partially purified biotin synthase, flavodoxin, and ferredoxin
(flavodoxin) NADP+ reductase fractions prepared by ion
exchange chromatography on a Q Sepharose Fast Flow column plus the
essential low molecular weight compounds were incubated with
dethiobiotin, no biotin was formed. Addition of MioC, either as a
partially purified fraction or as the purified protein (Fig.
2), resulted in the formation of biotin
(Fig. 3).

View larger version (108K):
[in this window]
[in a new window]
|
Fig. 2.
SDS-PAGE of MioC purified on the basis of its
activity in the biotin synthase reaction. Silver-stained 10-15%
SDS-PAGE gel (Phast system; Amersham Pharmacia Biotech) showing
fractions 25 from the final Mono Q column. An unstained SDS-PAGE gel
similar to this (normal format) was blotted onto a polyvinylidene
difluoride membrane and stained with Amido Black. The protein band was
cut out and sequenced. Lane 25 contains fraction 25 from the
Mono Q column. The far-right lane contains molecular mass
markers (Amersham Pharmacia Biotech): 14.4, 20.1, 30.0, 45.0, 66.0, and
97.0 kDa.
|
|

View larger version (40K):
[in this window]
[in a new window]
|
Fig. 3.
MioC is required for biotin synthase activity
in vitro. Biotin synthase activity was measured by the
conversion of [14C]dethiobiotin to
[14C]biotin. Substrate and product were separated by TLC
and detected by autoradiography. Lane 1, biotin standard;
lane 2, assay containing all standard components except for
a fraction containing MioC; lane 3, assay containing all
standard components plus the preparation of MioC from the first Q
Sepharose Fast Flow chromatography column (7); lane
5, assay containing all standard components plus fraction 25 from
the final Mono Q column (see Fig. 2).
|
|
We initially purified MioC, based on its activity in the biotin
synthase reaction, from 36.0 g of cells using a multi-step chromatographic procedure (Q Sepharose Fast-Flow, HiLoad Q Sepharose HP, Sephacryl S-100 HR, HiLoad 26/10 Phenyl Sepharose HP, Phenyl Superose HR5/5, heat treatment at 100 °C for 3 min, and further chromatography on Sepharose Blue Hi-Trap and Mono Q HR 5/5; details of
this purification are not given, because a more elegant purification scheme was designed after the protein was identified and cloned: see
"Materials and Methods") and obtained one fraction that contained pure MioC (fraction 25) as judged by SDS-PAGE analysis with silver staining (Fig. 2). Protein from a gel similar to that shown in Fig. 2
was blotted onto a polyvinylidene difluoride membrane, and the band at
~14 kDa was sequenced. The amino acid sequence was
Ala-Asp-Ile-Thr-Leu-Ile-Ser-Gly-Ser-Thr, which corresponded to amino
acids 2-11 of E. coli MioC.
Activity in the in vitro biotin synthase assay described
above was observed when fraction 25, which contained MioC, was included (Fig. 3). Although MioC was essential for biotin synthase activity in vitro, we calculated that the catalytic center activity
of the enzyme was less than 1. This is consistent with our earlier results and those from other groups (2, 3, 4, 7). MioC alone could not
replace either the flavodoxin or the ferredoxin (flavodoxin)
NADP+ reductase fractions, or both, in the assay.
Overexpression and Purification of MioC--
Expression of MioC to
~15% of the total soluble protein, as judged by SDS-PAGE analysis,
was achieved by the use of plasmid pMIO. Development of an efficient
expression system allowed the purification to be simplified to a
two-column procedure that yielded relatively large quantities of
protein, typically 200 mg from 100 g of cells (see "Materials
and Methods"). The initial chromatography step in the purification
was a Q Sepharose column. Analysis of the fractions by SDS-PAGE
revealed that MioC eluted in two peaks. The first peak was colorless
and was assumed to be the apoprotein. This was confirmed by amino acid
sequencing. The second peak was bright yellow, which was consistent
with the protein containing the bound cofactor. The holoprotein
represented approximately 25% of the total MioC protein. The presence
of the apoprotein was attributed to the high expression level of MioC,
with insufficient cofactor being biosynthesized or present in the
growth medium. A similar effect was not, however, observed for
flavodoxin, where the soluble expression levels were comparable with
those of MioC.
Identification of the Flavin Cofactor in MioC--
The UV-visible
absorption spectrum of MioC was characteristic of a flavoprotein, with
absorbance maxima at 373.5 and 446.5 nm (Fig.
4). From this spectrum it was not
possible to discriminate between FMN and FAD. However, electrospray
ionization mass spectrometry of MioC under negative ion conditions
showed a peak at 455.24 Da (Fig. 5). The
calculated mass of FMN is 456.3 Da, and that of FAD is 783.5 Da, so the
spectrum was consistent with FMN being the flavin cofactor bound to
MioC.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 5.
Electrospray ionization mass spectrometry of
MioC. The low molecular weight region shows a peak with a mass
corresponding to that of FMN.
|
|
Denaturation, by the addition of 5.0% trichloroacetic acid to MioC,
permitted the flavin cofactor to be released from the protein,
indicating that the flavin was noncovalently bound to the enzyme. FAD
and FMN standards could be separated by HPLC with retention times of
11.89 and 14.47 min, respectively. The supernatant from the MioC
extraction gave a retention time of 14.52 min, again confirming FMN as
the flavin cofactor.
Molecular Mass Determination--
The subunit molecular mass of
MioC predicted from the DNA sequence is 15,676 Da. Gel filtration
chromatography indicated that the apparent native molecular mass of
MioC was 31,500 Da when 100 mM Tris-HCl, pH 7.5, was used
as the running buffer, which may be explained if MioC exists as a dimer
under these conditions. The gel filtration experiments were repeated
together with flavodoxin, whose subunit molecular mass is 19,606 Da and with a range of NaCl concentrations in the running buffers. As
the NaCl concentration was increased, both MioC and flavodoxin eluted
later from the column. At 1.0 M NaCl the elution volume
corresponded approximately to that of the monomer for both proteins
(Table I). The apo form of MioC behaved
as for the holoenzyme. The elution volumes of MioC and flavodoxin were
not further affected when 2.0 M NaCl was added to the
running buffer.
View this table:
[in this window]
[in a new window]
|
Table I
The change in the molecular masses of MioC and flavodoxin after varying
the NaCl concentration during gel filtration chromatography
|
|
On native gel electrophoresis MioC ran with a lower apparent molecular
mass than trypsin inhibitor (20.1 kDa) and -lactalbumin (14.4 kDa)
standards and with a lower apparent molecular mass than expected for
the monomer (Fig. 6). This may be due to
the low pI value of MioC (the calculated pI for the MioC protein
sequence is 4.3), or MioC may be tightly folded.

View larger version (58K):
[in this window]
[in a new window]
|
Fig. 6.
Native PAGE of MioC. Lane 1,
trypsin inhibitor (20.1 kDa); lane 2, -lactalbumin (14.4 kDa); lane 3, MioC (15.7 kDa).
|
|
 |
DISCUSSION |
Biotin synthase, anaerobic ribonucleotide reductase activating
enzyme (AE), and pyruvate formate lyase AE all utilize flavodoxin, ferredoxin (flavodoxin) NADP+ reductase, NADPH, and
S-adenosylmethionine and contain an Fe-S cluster. In
contrast to biotin synthase, the 5'-deoxyadenosyl radical formed by
the reductive cleavage of S-adenosylmethionine by pyruvate
formate lyase AE and anaerobic ribonucleotide reductase AE abstracts a
hydrogen atom to give a protein-based radical, which then reacts with
the substrate (20, 21). The requirement for further additional proteins
for activity also distinguishes biotin synthase from the pyruvate
formate lyase and anaerobic ribonucleotide reductase enzyme systems.
Unlike biotin synthase, both anaerobic ribonucleotide reductase AE and
pyruvate formate lyase AE are catalytic in vitro and have
fully defined assay systems.
The mioC gene is located next to oriC on the
E. coli chromosome and although several investigations have
tried to establish a role for mioC transcription in
chromosome replication (22-24), the results were inconclusive (25,
26). To date, no function for MioC has been established. We have now
shown that MioC is essential for E. coli biotin synthase
activity in vitro.
When highly purified biotin synthase was incubated with photo-reduced
deazaflavin in the absence of any other proteins, it was active (27).
This suggests that photo-reduced deazaflavin can replace both the
NADPH, flavodoxin, and ferredoxin (flavodoxin) NADP+
reductase electron transport system and MioC. In addition, sequence comparison studies predicted that MioC had a similar structure to
flavodoxin and a flavin-binding motif (28), and we have provided experimental evidence that it binds FMN. Based on these observations, we propose that MioC is part of the electron transport system for
biotin synthase. Our results can most easily be explained by MioC
transferring electrons from flavodoxin to the Fe-S cluster of biotin
synthase. Although the NADPH ferredoxin (flavodoxin) NADP+ reductase flavodoxin electron transport pathway
has recently been verified by redox potentiometry (8), the reduction
potential of the Fe-S cluster of biotin synthase remains unknown, and
hence the final electron transfer step from flavodoxin to biotin
synthase has not been confirmed.
Biotin synthase has not yet been shown to catalyze the conversion of
dethiobiotin to biotin in vitro. The Fe-S cluster of biotin
synthase provides the sulfur atom for the dethiobiotin to biotin
conversion (4, 12), so that Fe-S cluster forming or reforming enzymes
may also be required for activity. The absence of these and MioC may be
partly responsible for the very low catalytic center activity of the
enzyme in the assay system with photo-reduced deazaflavin and highly
purified biotin synthase (between 0.04 and 0.08/h, calculated from the
results in Ref. 28).
The x-ray crystal structure of E. coli flavodoxin (Protein
Data Bank file code 1ag9) shows that it crystallizes with two molecules
in the asymmetric unit. Calcium, sodium, and chloride ions form salt
bridges between the two molecules. Determination of the native
molecular mass of MioC by gel filtration chromatography in low salt
conditions showed MioC to be a dimer, but at relatively high salt
concentrations (1.0 M NaCl) it behaved as a monomer, which
is consistent with the disruption of intermolecular salt bridges.
During the original purification of MioC, where its activity in the
biotin synthase reaction was measured, the addition of TPP to the
buffers helped to maintain its activity. MioC has no TPP binding site,
and following purification, TPP had no effect on its activity in the
assay. We have no explanation for the positive effect of TPP during purification.
In conclusion, we have shown that MioC is required for biotin synthase
activity in vitro. We suggest that MioC may have an electron
transport role based on its predicted similarity to flavodoxin and its
binding of FMN, and the fact that it can be replaced in the biotin
synthase assay in vitro by photo-reduced deazaflavin. Despite inclusion of MioC in the biotin synthase assay, catalytic activity was still not observed. Unknown factors, such as Fe-S cluster
forming enzymes, may have been missing. Further experiments are
required to confirm the role of MioC in vivo and as part of a catalytic system for the formation of biotin.
 |
ACKNOWLEDGEMENTS |
We thank Dr. R. T. Aplin for mass
spectroscopy, Dr. M. Gross for CD analysis, and H. McNaughton for
fluorescence spectroscopy.
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
Supported by the Biotechnology and Biological Sciences
Research Council and Lonza U.K.
**
Recipient of a Royal Society University Research Fellowship.

To whom correspondence should be addressed. Tel.:
41-279-485937; Fax: 41-279-475937; E-mail:
nicholas.shaw@lonzagroup.com.
Published, JBC Papers in Press, July 25, 2000, DOI 10.1074/jbc.M004497200
 |
ABBREVIATIONS |
The abbreviations used are:
Fe-S cluster, iron-sulfur cluster;
TPP, thiamine pyrophosphate;
PAGE, polyacrylamide
gel electrophoresis;
AE, activating enzyme;
HPLC, high pressure liquid
chromatography.
 |
REFERENCES |
| 1.
|
Flint, D. H.,
and Allen, R. M.
(1997)
Methods Enzymol.
279,
356-362
|
| 2.
|
Shaw, N. M.,
Birch, O. M.,
Tinschert, A.,
Venetz, V.,
Dietrich, R.,
and Savoy, L.-A.
(1998)
Biochem. J.
330,
1079-1085
|
| 3.
|
Sanyal, I.,
Gibson, K. J.,
and Flint, D. H.
(1996)
Arch. Biochem. Biophys.
326,
48-56
|
| 4.
|
Tse Sum Bui, B.,
Florentin, D.,
Fournier, F.,
Ploux, O.,
Méjean, A.,
and Marquet, A.
(1998)
FEBS Lett.
440,
226-230
|
| 5.
|
Ohshiro, T.,
Yamamoto, M.,
Izumi, Y.,
Tse Sum Bui, B.,
Florentin, D.,
and Marquet, A.
(1994)
Biosci. Biotechnol. Biochem.
58,
1738-1741
|
| 6.
| Birch, O. M., Brass, J. M., Fuhrmann, M., and Shaw N. M. (April 14, 1994) Patent Cooperation Treaty Patent Application WO
94/08023
|
| 7.
|
Birch, O. M.,
Fuhrmann, M.,
and Shaw, N. M.
(1995)
J. Biol. Chem.
270,
19158-19165
|
| 8.
|
McIver, L.,
Leadbeater, C.,
Campopiano, D. J.,
Baxter, R. L.,
Daff, S. N.,
Chapman, K.,
and Munro, A. W.
(1998)
Eur. J. Biochem.
257,
577-585
|
| 9.
|
Ifuku, O.,
Koga, N.,
and Haze, S.
(1994)
Eur. J. Biochem.
224,
173-178
|
| 10.
|
Guianvarc'h, D.,
Florentin, D.,
Tse Sum Bui, B.,
Nunzi, F.,
and Marquet, A.
(1997)
Biochem. Biophys. Res. Commun.
236,
402-406
|
| 11.
|
Escalettes, F.,
Florentin, D.,
Tse Sum Bui, B.,
Lesage, D.,
and Marquet, A.
(1999)
J. Am. Chem. Soc.
121,
3571-3578
|
| 12.
|
Gibson, K. J.,
Pelletier, D. A.,
and Turner, I. M., Sr.
(1999)
Biochem. Biophys. Res. Commun.
254,
632-635
|
| 13.
|
Zheng, L.,
Cash, V. L.,
Flint, D. H.,
and Dean, D. R.
(1998)
J. Biol. Chem.
273,
13264-13272
|
| 14.
|
Nakamura, M.,
Saeki, K.,
and Takahashi, Y.
(1999)
J. Biochem. (Tokyo)
126,
10-18
|
| 15.
|
Takahashi, Y.,
and Nakamura, M.
(1999)
J. Biochem. (Tokyo)
126,
917-926
|
| 16.
|
Osborne, C.,
Chen, L. M.,
and Matthews, R. G.
(1991)
J. Bacteriol.
173,
1729-1737
|
| 17.
|
Hughes, G. J.,
Frutiger, S.,
Paquet, N.,
and Jaton, J.-C.
(1990)
Biochem. J.
271,
641-647
|
| 18.
|
Sambrook, J.,
Fritsch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual
, 2nd Ed
, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
|
| 19.
|
Burland, V.,
Plunkett, G.,
Daniels, D. L.,
and Blattner, F. R.
(1993)
Genomics
16,
551-561
|
| 20.
|
Becker, A.,
Fritz-Wolf, K.,
Kabsch, W.,
Knappe, J.,
Schultz, S.,
and Wagner, A. F. V.
(1999)
Nat. Struct. Biol.
6,
969-975
|
| 21.
|
Mulliez, E.,
Ollagnier, S.,
and Fontecave, M.
(1999)
in
Iron Metabolism
(Ferreira, G. C.
, Moura, J. G.
, and Franco, R., eds)
, Wiley-VCH Verlag GmbH, Weinheim, Germany
|
| 22.
|
Løbner-Oleson, A.,
Atlung, T.,
and Rasmussen, K.
(1987)
J. Bacteriol.
169,
2835-2842
|
| 23.
|
Asai, T.
(1991)
Jpn. J. Genet.
66,
85-107
|
| 24.
|
Ogawa, T.,
and Okazaki, T.
(1994)
J. Bacteriol.
176,
1609-1615
|
| 25.
|
Løbner-Oleson, A.,
and Boye, E.
(1992)
Nucleic Acids Res.
20,
3029-3036
|
| 26.
|
Bates, D. B.,
Boye, E.,
Asai, T.,
and Kogoma, T.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
12497-12502
|
| 27.
|
Méjean, A.,
Tse Sum Bui, B.,
Florentin, D.,
Ploux, O.,
Izumi, Y.,
and Marquet, A.
(1995)
Biochem. Biophys. Res. Commun.
217,
1231-1237
|
| 28.
|
Grandori, R.,
and Carey, J.
(1994)
Protein Sci.
3,
2185-2193
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. A. Cotruvo Jr. and J. Stubbe
NrdI, a flavodoxin involved in maintenance of the diferric-tyrosyl radical cofactor in Escherichia coli class Ib ribonucleotide reductase
PNAS,
September 23, 2008;
105(38):
14383 - 14388.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Hu, Y. Li, X. Zhang, X. Guo, B. Xia, and C. Jin
Solution Structures and Backbone Dynamics of a Flavodoxin MioC from Escherichia coli in both Apo- and Holo-forms: IMPLICATIONS FOR COFACTOR BINDING AND ELECTRON TRANSFER
J. Biol. Chem.,
November 17, 2006;
281(46):
35454 - 35466.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Picciocchi, R. Douce, and C. Alban
The Plant Biotin Synthase Reaction: IDENTIFICATION AND CHARACTERIZATION OF ESSENTIAL MITOCHONDRIAL ACCESSORY PROTEIN COMPONENTS
J. Biol. Chem.,
June 27, 2003;
278(27):
24966 - 24975.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Picciocchi, R. Douce, and C. Alban
Biochemical Characterization of the Arabidopsis Biotin Synthase Reaction. The Importance of Mitochondria in Biotin Synthesis
Plant Physiology,
November 1, 2001;
127(3):
1224 - 1233.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|